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A B S T R A C T
Background: Sepsis is the leading cause of mortality in critically ill patients. Procalcitonin (PCT) is a promising
marker for identification of bacterial sepsis. The aim of this study was to determine the diagnostic accuracy of
serum PCT concentration in patients with suspected sepsis admitted to mixed medical-surgical Intensive care
unit (ICU).
Material and methods: A cross-sectional study conducted at section of Chemical Pathology, Department of
Pathology and Laboratory Medicine and ICU. Patients with suspected sepsis were included, serum PCT cut off
≥0.5 ng/ml was taken for diagnosing sepsis. Diagnostic accuracy was measured in terms of sensitivity, speci-
ficity, positive predictive value (PPV) and negative predictive value (NPV) taking blood culture as gold standard.
Furthermore, different cut offs were compared by using receiver operating characteristic curves (ROC). Data
analysis was done on SPSS version 20.
Results: Median age of the study group (n=103) was 48 years (IQR: 22), 60% being males. Out of the 103
patients included 82 patients had PCT levels above the optimal cut off. At a serum PCT cutoff of 0.5 μg/L, the
sensitivity and specificity for the diagnosis of sepsis was found to be 93.75% and 43.59% respectively. NPV was
higher compared to PPV making PCT a reliable marker to for the screening out of sepsis patients. Furthermore, it
was revealed that PCT having an AUC=0.70 outperformed WBC (AUC=0.5) and CRP (AUC=0.6).
Conclusion: Elevated PCT concentration is a promising indicator of sepsis in newly admitted critically ill patients
capable of complementing clinical signs and routine laboratory parameters.
1. Introduction
The past century has witnessed a rising trend in the incidence of
infections, sepsis, and septic shock regardless of overwhelming devel-
opment in treatment modalities [1]. Sepsis is a common condition that
exists in patients admitted to intensive care units (ICU). Audits of ICU
worldwide showed that 29.5% patients had sepsis on admission or
during the ICU stay [2]. According to a study undertaken in 150 ICUs
across 16 Asian countries; 28.3% of all admissions in participating units
from Pakistan had sepsis [3].
Microbiological culture testing remains the traditional gold stan-
dard diagnostic modality for identification of sepsis with its own lim-
itations. Prolong turnaround times for culture and the fact that blood
cultures detect bacteraemia in only about 50% of patients with clinical
suspicion of sepsis pose diagnostic challenge for septic patients in ICU
[4]. Diagnosis is optimised by using biochemical tests for sepsis, such as
C - reactive protein (CRP) or leukocyte count (WBC) which have re-
portedly low diagnostic accuracy and are at times ambiguous [5].
Search for new markers for providing early diagnosis with improved
sensitivity and specificity continues. Procalcitonin (PCT) has developed
as an ideal biomarker for sepsis and early detection of bacteraemia as it
can be quantified and promptly interpreted in light of clinical context to
aid decision making in patient care [6]. PCT has been used as marker of
sepsis with sensitivity and specificity of 83% and 62% respectively with
significantly high levels in the patients having sepsis and positive blood
culture results than with culture negative results [7,8].
PCT is a glycoprotein present in C cells of thyroid gland. It belongs
to the group of related peptide (C-GRP) encoded by the CALC-1 gene
and is formed from the common precursor pre-calcitonin [9]. In healthy
subjects, CALC-1 genes synthesize Calcitonin, but presence of microbial
infection through endotoxin or pro-inflammatory cytokines increases
calcitonin gene expression and PCT mRNA is mostly synthesised. This
leads to release of PCT from all parenchymal tissue, exclusively in re-
sponse to bacterial infection only and not viral or inflammatory disease
[10]. This makes PCT to be a specific diagnostic marker to detect
bacterial sepsis. On the other hand serum levels of PCT increase briskly
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within 2–6 h after the stimulus making it a rapid diagnostic marker
compared to culture [11,12].
As the expression of PCT depends upon the genetic framework of the
population, therefore, it is important to assess its role and utility in
Pakistani population with different metabolic and biochemical makeup.
The aim of this study was to determine the diagnostic accuracy of PCT
in diagnosis of bacterial sepsis in critically ill patients admitted at ICU
of Aga Khan University Hospital Karachi (AKUH-K), by taking blood
culture as gold standard.
2. Methods
This interdisciplinary cross sectional study was conducted in the
Section of Chemical Pathology, Department of Pathology & Laboratory
Medicine and mixed medical-surgical ICU of AKUH-K, Pakistan. The
study was approved by the institutional Ethical Review Committee
(1573-Pat-ERC-11). Our study was registered with NIH clinicaltrials.
gov (Unique ID: NCT03506152). The work has been reported in line
with the Strengthening the Reporting of Cohort Studies in Surgery
(STROCSS) criteria [13].
2.1. Inclusion criteria
Adult male and female patients between 18 and 70 years of age with
a clinical suspicion of sepsis as guided by the ICU physicians were re-
cruited through non-probability purposive sampling, within 24 h of ICU
admission during January to December 2014. The criteria of suspected
sepsis was used for labelling the cases included the presence of any two
or more of the following conditions at the time of admission: tem-
perature ≥38 °C or< 36 °C, heart rate> 90 beats/min, respiratory
rate> 20 breaths/min, white blood cell count< 4×109/L (< 4000/
mm³),> 12×109/L (> 12,000/mm3). Sepsis was further confirmed
by the presence of positive blood culture. Furthermore other markers of
sepsis including CRP levels, WBC counts and blood culture undertaken
at the time of admission as a part of routine care were also recorded.
2.2. Exclusion criteria
Patients above 70 years of age were excluded due to ‘immune se-
nescence’ in elderly giving rise to different presentation of bacteraemia.
Furthermore, patients discharged before 24 h, patients who had blood
transfusion before ICU stay and those with organ failure were excluded
from the study.
Data was collected on predesigned forms by the team of primary
investigators. Patients were recruited after informed consent from im-
mediate family members/care takers.
Seven ml of blood was drawn in gel separator tubes within 24 h of
admission in ICU for PCT determination. Blood samples were cen-
trifuged at 3000 rpm and serum was separated and stored at −20 °C
until assayed. Serum PCT was measured by Electro-
Chemiluminescence immunoassay (ECLIA) on the Roche Elecsys E170
immunoassay analyser using manufacturer's recommendations. Results
are expressed as micro gram of PCT per litre of serum (ug/L). For in-
ternal quality control 2 levels of manufacturer provided controls [low
and high] were run with each batch of analyte while samples from
College of American Pathologists (CAP, USA) were run for external
quality control. PCT levels> 0.5 μg/L are considered positive for di-
agnosis of sepsis.
A sample size of 103 was calculated by using PASS 11 word home
edition software by taking the sensitivity 83%, specificity 62%,
Prevalence 37.4% [14] and precision 10%.
Data analysis was done on SPSS version 20. Shapiro Wilk test was
used to check normality of data. As the data that was skewed; median
values were reported along with interquartile ranges (IQR) for quanti-
tative variables. Diagnostic accuracy of PCT was calculated on the basis
of sensitivity, specificity, PPV and NPV taking blood culture as gold
standard. For further analysis, Receiver operative characteristic (ROC)
curve was plotted for PCT and area under the curve (AUC) calculated.
Furthermore, association between CRP, WBC and PCT was done using
ROC curve and respective AUC were compared.
3. Results
One hundred and three patients met inclusion criteria and were
included in the final study analysis as shown in Fig. 1. Sixty percent of
the patients were males (n=62). The median age of the group was 48
years (IQR: 22) and BMI was 25.4 kg/m2 (IQR: 4.22). Out of the 103,
43.7% were obese and 8.7% were overweight according to Asian BMI
classification [15]. Median PCT levels were 1.5 μg/L (IQR: 8.5 μg/L),
79% (n=82) patients had PCT levels> 0.5 μg/L (median PCT 2.7 μg/
L).
Sixty four patients had bacterial growth on blood culture while 39
samples did not show growth over a period of 5 days. Among the
various organisms identified on culture Escherichia coli (E.Coli) (n= 21)
and Staphylococcal infections (n= 22) were the most frequent as de-
picted in Fig. 2.
PCT levels with a median value of 2.14 μg/L in the culture positive
group, were found to be significantly higher compared to culture ne-
gative group (p value < 0.01). Furthermore, median CRP levels and
median WBC levels were also higher in the culture positive groups as
shown in Table 1. The sensitivity and specificity for the diagnosis of
sepsis compared to culture as gold standard was found to be 93.75%
(95% CI: 84.76%–98.27%) and 43.59% (95% CI: 27.81%–60.38%) re-
spectively. NPV was calculated to be 80.95% and was higher compared
to PPV (73%) making PCT a better marker for screening of patients with
sepsis.
Fig. 1. Distribution of consort showing critically ill patients included in final
analysis with suspected sepsis from medical and surgical ICU.
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ROC curve analysis was used to compare the performance of PCT
with the other two markers of sepsis recorded for each study partici-
pant. PCT having an AUC=0.7 outperformed WBC (AUC=0.5) and
CRP (AUC=0.6). Fig. 3 illustrates the ROC curve results for PCT, WBC
and CRP compared to culture results.
Diagnostic performance of PCT at various cut offs was evaluated.
Performance of PCT at various cut offs is shown in Table 2. PCT cut-off
of 1.5 μg/L has better specificity for diagnosing sepsis when compared
to a cut-off of 0.5 μg/L; at the cost of sensitivity.
4. Discussion
To date no gold standard test has been identified for diagnosis of
sepsis because culture results may be affected by various pre analytical
issues including pre-treatment with antibiotics and inadequate and in-
appropriate sampling. Moreover results of microbiological studies are
not immediately available and in most cases the turnaround time ex-
ceeds the time line for a swift diagnosis. A biomarker like PCT that
possesses rapid kinetics and has acceptable diagnostic accuracy for
identifying sepsis is needed for laboratories as well as clinicians.
To the best of our knowledge this is the first study exploring the
accuracy of PCT for the diagnosis of bacterial sepsis in critically ill adult
patients in ICUs from Pakistan. Most studies from Pakistan aimed at
diagnostic utility of PCT are undertaken in the neonates and children
[5,16]. Our study population was a large, diverse group of critically ill
adult patients with sepsis, admitted to the ICU. Patients were classified
into having suspected sepsis on the basis of the 1991 ACCP/SCCM
Sepsis Directory and the diagnostic criteria advanced by the 2001
International Sepsis Definition Conference [17]. Furthermore, these
findings were also confirmed by the ICU consultants.
Our study reported a male predominance with sepsis (60%), another
study conducted at our centre undertaken over a period of two years
from 2012 to 2013 has reported that 209 patients admitted to the
surgical ICU had sepsis; with a male predominance of 67.6% which is
correlating with our findings [18]. Similarly studies from other centres
and a multicentre trial from India also reported higher rates of sepsis
associated with male gender compared to females [19,20].
Additionally, higher WBC counts reported in our study are in
agreement with various studies which have also evaluated the efficacy
of WBC as a marker of sepsis and have reported higher counts in case of
culture proven sepsis [21–23].
Based on data collected by the European Antimicrobial Resistance
Surveillance Network (EARS-Net) and the former EARSS, Escherichia
coli and Staphylococcus aureus are the main causes of bloodstream in-
fections in humans [24]. And our study seconds these findings.
The PCT cut off employed by ICUs worldwide for diagnosis of sepsis
greatly varies. At a serum PCT cutoff of 0.5 μg/L, our study has reported
a sensitivity and specificity of 93.75% and 43.59% respectively. The
diagnostic efficacy of PCT was further tested with receiver operating
characteristic curves compared to culture which revealed an AUC of
0.7. The cut off that maximizes the area under the curve for sepsis di-
agnosis is found to be 1.5 μg/L. This cut off has a better specificity
compared to a cut off 0.5 μg/L. Furthermore, this is in concordance with
various published studies. Results summarized in Table 3.
Therefore, we recommend that for differentiating bacterial sepsis
from other causes of sepsis a cut-off of 1.5 μg/L should be utilized by
adult ICUs in our population.
There were some limitations of this study; serial measurement of
PCT were not undertaken to report the kinetics and PCT could also be
falsely negative in early course of infection which warrants treatment.
Additionally any localized infections e.g. osteomyelitis, abscess can also
present with PCT values below the cut off. Antibodies testing for viral
infections were not done; similarly fungal cultures were not performed
to rule out fungal infections. The sample size was small limiting the
power of the present study and there is a likelihood that large scale
studies in Pakistani ICU may differ from our findings. A small subset of
patients (n= 12) in our study however presented with markedly ele-
vated procalcitonin levels but negative culture results ranging from
Fig. 2. Showing culture results (n= 64).
Table 1
Comparison of Biomarkers of Sepsis in Culture Positive and Negative Groups in
critically ill patients Admitted in ICU [n=103].
Biomarker [Reference
Range]
Culture positive
group [n=64]
Culture negative
group [n=39]
p- value
Median [IQR] Median [IQR]
PCT [< 0.5 μg/L] 2.14 [10.21] 0.8 [3.76] 0.001a
CRP [0–5mg/L] 98 [125] 86 [138] 0.239
WBC [4.0-10× 109/L] 14.3 [10.53] 12.8 [8.2] 0.314
a p value < 0.01=highly significant.
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3.12 to 100 μg/L. Most of the patients in this group presented with
sepsis secondary to respiratory tract infections (RTIs) (n= 8). Blood
cultures are reported to be less accurate predictors of RTIs compared to
sputum culture and might lead to discrepant outcomes [33]. Another
factor to consider in our study setup was the possibility of patients
receiving antibiotic treatment before cultures were obtained, hence
resulting in false-negative culture results. Furthermore one patient in
our study with elevated PCT presented with malarial infection and
negative cultures, which is in concordance with other studies that have
witnessed elevation of PCT in malaria [34,35].
This study demonstrates PCT to be promising marker of sepsis in
critically ill patients. However we recommend that PCT values must be
considered in conjunction with clinical examination and other labora-
tory tests while implementing the therapeutic plan. Thus to conclude
adding PCT to the list of standard laboratory work up of critically ill
patients with suspected sepsis could increase diagnostic accuracy
leading to improved patient care.
Fig. 3. ROC analysis of PCT, CRP and WBC against culture as gold standard. (For interpretation of the references to colour in this figure legend, the reader is referred
to the Web version of this article.)
Table 2
Performance of PCT at various cut offs for sepsis diagnosis compared to culture.
PCT
Cut off [μg/L]
Sensitivity [%] Specificity [%]
0.5 93.8 43.5
1 71.9 57
1.5 64 70
2 51 70
2.5 51 70
Table 3
Comparison of diagnostic accuracy of PCT for diagnosis of sepsis with other
studies at a cut off of 0.5 μg/L and 1.5 μg/L.
Comparison of diagnostic accuracy of PCT for diagnosis of sepsis with other studies at a
cut off of 0.5 μg/L
Country n Sensitivity [%] Specificity [%]
Aw TC et al.
[25]
Singapore 626 79.6 47.2
Bossink et al.
[26]
Netherlands 133 65 58
Luyt et al. [27] France 172 72 24
Sudhir et al.
[28]
India 100 94 Not reported
Alzahrani et al.
[29]
Saudi Arabia 109 54.4 65.9
Our study Pakistan 103 93.8 43.5
Comparison of diagnostic accuracy of PCT for diagnosis of sepsis with other
studies at a cut off of 1.5 μg/L
Country n Sensitivity
[%]
Specificity [%]
Du et al. [30] China 51 80 74
Wanner et al.
[31]
Switzerland 133 76 77
Tugrul et al.
[32]
Turkey 85 73 80
Our study Pakistan 103 64 70
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